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ThrombinandRheologicFactors- Clinical
Relevsnceforthe Developmentof Restenosis
FollowingElectivePTCAin PatientaWithStable
AnginaPectoris
F.C. Schoebel, F. Gradaus, T.W.Jax, M. Heins, D. Stein, M. Berries,
M. Leschke, B.E. Strauer. Clinic of Cardiology FfeirrrichHeineUniversity
Dtieeeldorf,Germany
Thrombmis secondary to severe vascular injury following PTCA is regarded
to be a confounding faotor in the pathogenesis of restenosis. The potential
relevance of hemostatic risk factors has not been conclusively clarified so
far.
In 48 consecutive patients, who underwent elective and primarily suc-
cessful PTCA, fibrinogen (Fib), prothrombinfragment 1 + 2 (F1 + 2), plasma
viscosity (PV), red cell aggregation (RBC) and endogenous fibrinolysis (tis-
sue plasminogen activator antigen (t-PA), plasminogen activator inhibitor
activity (PAI), plasmin 2 antiplasmin (PAP) were assesed prior to cardiac
catheterization. Angiogrephic results were evaluated by quantitative mro-
nary angiography.
Of these patients 14 (30%) suffered restenosis (stenosis >50%) and
in comparison to patients without restenosis demonstrated elevations of
fibrinogen (350 + 57vs. 305 + 8S mg/dl, p < 0.05), PV (1.37+ 0.07 vs. 1.32
+0.08 mPas, p < 0.05), RBC (14.0 +2.9 vs. 11.3+2.8 U, p < 0.01) and FI
+ 2 (1.4+0.38 vs. 0.87+0.38 nmolil, p < 0.05). PAI (4.12+ 1.88vs. 5.15+
3.33 U/ml, n.s.), t-PA (9.00 3=3.02vs. 8.85+ 2.8 n~ml, n.s.) and PAP(458 +
180 vs. 394 + 128 @l)as well es procedural variables of angioplasty did not
differ significantly. Discriminative analysis revealed generation of thrombin
(F1 +2) to be the moat important faotor for the oocurence of restenosis and
late Iuminal Ioaacorrelated significantly with FI +2 (r= 0.38). In patients with
FI + 2> 1.1 nmolll and RBC >12.3 U the rate of restenoaiawas 87%.
The results indicate that thrombin generation (F1 * 2) and rheologic
factors as aaaesed prior to mechanical injwy have an influence on late
restenosis following coronary angkpleety,Wfrichmaycontributeto a risk
stratified use of antithrombotic therapy.
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adhealonmoleculeICAM-1butnotELAM-1during
episodesof anginapectoris
T. Siminiak’,z, J. Smielecki, J.F. Dyez, M. Balinaki, R. Morez,
H. Wyaccki 1, D.J. Sheridanz. 1UniversitySchoolof fdedicslSciences,
Poznan,Poland,2ImperialCollegeof Medicineat St.Mary’s,London,UK
Background:Myocardial ischemia is known to result in activation of neu-
trophils, which subsequently adhere to endothelial cells via surface adhesion
moleoules expressed by both cell types. Leukocyte adhesion to the endothe-
Iium may result in coronary capillary plugging and impairment of coronary
blood flow. Adhesion moledes such as ICAM-I and E-selectin (EIAM-1)
may be shed from the endothelial cell surface into the circulation and be
detected in their soluble form.
Aim: The purpoee of this study was to verify whether the myocardial
iechemia occurrfng during angina episodee was associated with increased
release of the soluble adhesion moleoules ICAM-I and ELAM-I.
Methods:Plasma samples were obtained during pain (DP) from 15 pa-
tients admitted to the emergency room with angina and 15 patients with
non-oardiac chest pain (NCCP). To mnfirm diagnosis, patients underwent
exercise stress test and, if not conclusive, T& MIBI SPECT or angicgraphy.
Convalescent sample was also taken from each patient in the absence of
pain (AP). In addition, samples were obtained from 15 age-matched healthy
controls. Plasma levels of solubla ICAM-1 and El-AM-l were measured by
sensitive ELlSA assays.
Results:
Angina pts Pts wilh NCCP Controls
DP AP DP AP
sICAM 338* 37* 272&33 239l22 231+29 220+ 18
sELAM 48.1*4.7 44.3* 5.1 46.1l7.8 4s.3* 6.0 43.6* 3.7
Mean+ SEM,n~ml;*p c 0.05vs.controls.
Conclusion:During angina episodes a selective increase in plasma level
of the soluble adhesion molecula ICAM-I was noted, possibly reflecting
endothelial cell activation during myocardial iechemia.
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IeelevetedplsemahistamineIevelainthecoronary
venousbloodassociatedwithdiaeaeeactivityin
variantangina?
Y.Sakata, A. Hirayama, F. Ishikura, K. Komamura, H. Fuji, H. Yamamoto,
K. Kodama. OsakaPolice Hospital,Osaka,Japan
It has been debated whether plasma histamine, a potent vasoconstrictor, is
associated with the pathogenesis of variant angina. We measured plasma
histamine concentration (PHC) in the great cerdiacvein (GCV) in 19 patienta;
4 patients with unstable variant angina (UVA) defined as new or worsening
angina at rest, 7 patients with stable variant angina (SVA) whose anginal
attacks were well controled by drug therapy, and 8 control patients. lntra-
coronaty administration of acetylcholine provoked significant vaaospasm in
the proximal lesion of the Ieftanterior descending coronary in all patients with
UVA and SVA. Blood was sampled from the 5 Fr. NIH catheter ~itioned at
GCV every four hours over a night in all patienta. We detected alevation of
PHC in all UVA (100%, P <0.01 vs control), 5 of 7 SVA (71%, P <0.01 VS.
control) and none of control patients. Similarly, PHC elevation was observed
in 14 of 18 UVA (78%, P <0.001 vs. SVA and mntrol), 12 of 30 SVA (40%,
P <0.001 vs. control) and none of control aampling points. During all the
procedures, spontaneous anginal attacks were documented in 3 patients,
which occurred at their maximal values of PHC.
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Thus, our results showed that elevation of PHC in the coronary venous
bloat was commonly obaewed in patients with variant angina, which was
associated with disease activity. Conclusively, the preaent atudy presented
clinical evidence that histamine may wall be related to episodes of variant
angina as suggested in animal studies.
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~781-1 I DirectAngioPleStYMaYBeLeeaAdvantS9e0uSin
PatientsPresentingEsrlyAfterSymptomOnset:
ReaulteFromGUSTOIlb
C.B. Grenger, H.R. Phillips, A. Betriu, S.G. Ellis, W.D. Weaver, P.Aylward,
A. Stebbina, K.L. Lee, R.M. Califf, E.J. Topol for the GUSTO-llb
Investigators DukeUniversityMedicalCenter,Durham,NC,USA
In order to evaluate the relationship betwean time from symptom onset and
the benefit of direct angioplasty, we examined the outcomes of 30-day death
and the primary endpoint of death, reinfarction, or disabling stroke in the
GUSTO Ilb direct PTCA substudy according to time to randomization. 1099
patients with available time date were enrolled within 12 houra of aymptom
onset with ST elevation from 57 centers in 9 countries, and were randomized
to either accelerated dose t-PA or diract angioplasty.
Tms to randomization PTCA(n. 543) t-PA(n= 556) OddsRatio(95%CI)
O-4 hours(n= 824)
Death 6.00/0 5.9’% 1.01 (0.57, 1.81)
Death, reMl, stroke 10,O”A 12,1”/. 0.S1 (0.52, 1.25)
>4 hours(n = 275)
Death 5,6% 11,34A 0.47 (0.19, 1.15)
Death. reM1.stroke 9.9% 18.8% 0.47 (0.23. 0.95)
When time to enrollment was examined as a mntinuous variable, there
was no statistically significant difference in treatment effect of direct angio-
